Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065922 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marion Courtalin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, University of Lille, 59000 Lille, France. Hauptthemen laut MEDLINE: Bone Marrow, Adiposity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSD (France), French Society of Rheumatology.
Abstract (Originalsprache)
Sclerostin is a Wnt signaling pathway inhibitor that negatively regulates bone formation. Bone-marrow-derived stromal cell (BMSC) differentiation is influenced by the Wnt pathway, leading to the hypothesis that higher levels of sclerostin might be associated with an increase in bone marrow adiposity (BMA). The main purpose of this study was to determine whether a relationship exists between circulating sclerostin and BMA in post-menopausal women with and without fragility fractures. The relationships between circulating sclerostin and body composition parameters were then examined. The outcomes measures included vertebral and hip proton density fat fraction (PDFF) using the water fat imaging (WFI) MRI method; DXA scans; and laboratory measurements, including serum sclerostin. In 199 participants, no significant correlations were found between serum sclerostin and PDFF. In both groups, serum sclerostin was correlated positively with bone mineral density (R = 0.27 to 0.56) and negatively with renal function (R = −0.22 to −0.29). Serum sclerostin correlated negatively with visceral adiposity in both groups (R = −0.24 to −0.32). Serum sclerostin correlated negatively with total body fat (R = −0.47) and appendicular lean mass (R = −0.26) in the fracture group, but not in the controls. No evidence of a relationship between serum sclerostin and BMA was found. However, serum sclerostin was negatively correlated with body composition components, such as visceral adiposity, total body fat and appendicular lean mass.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, University of Lille, 59000 Lille, France.
- Laboratory MABlab ULR 4490, 59000 Lille, France.
- Department of Radiology, University of Lille, 59000 Lille, France.
- METRICS-Evaluation des Technologies de Santé et des Pratiques Médicales, University of Lille, 59000 Lille, France.
ORCID-Profile: Sammy Badr, Alexandrine During, Bernard Cortet, Aline Clabaut, Julien Paccou
Förderung
- MSD (France)
- French Society of Rheumatology
Zitieren
APA
Courtalin, M., Bertheaume, N., Badr, S., During, A., Lombardo, D., Deken, V., Cortet, B., Clabaut, A., & Paccou, J. (2023). Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065922
Vancouver
Courtalin M, Bertheaume N, Badr S, During A, Lombardo D, Deken V, et al. Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065922
BibTeX
@article{Courtalin2023,
author = {Courtalin, Marion and Bertheaume, Nicolas and Badr, Sammy and During, Alexandrine and Lombardo, Daniela and Deken, Valérie and Cortet, Bernard and Clabaut, Aline and Paccou, Julien},
title = {Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065922}
}
EUVIMED